Central neuropeptide responses can be inhibited by sumatriptan [68], olcegepant, a small molecule CGRP antagonist, and a 5HT1F antagonist (ditan) [73], all drugs proven to be clinically efficacious in migraine [74]. This evidence concerns the gene CALCA and migraine disorder.